Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(2-[[(1-benzofuran-2-carbonyl)amino]methyl]-5-methoxy-1H-indol-1-yl)acetic acid
-
-
(2-[[(1-benzofuran-2-sulfonyl)amino]methyl]-5-methoxy-1H-indol-1-yl)acetic acid
-
(2-[[(1-benzofuran-2-yl)methoxy]carbonyl]-5-methoxy-1H-indol-1-yl)acetic acid
-
(2RS)-5'-O-(2-hydroxy-4-methoxybutyrylsulfamoyl)adenosine
-
(2RS)-5'-O-(3,3-dimethyl-2-aminobutyrylsulfamoyl)adenosine
-
(2RS)-5'-O-(3,3-dimethyl-2-hydroxy-4-methoxybutyrylsulfamoyl)adenosine
-
(2RS)-5'-O-(3,3-dimethyl-2-hydroxybutyrylsulfamoyl)adenosine
-
(2RS)-5'-O-(3,3-dimethyl-2-oxobutyrylsulfamoyl)adenosine
-
(2RS)-adenosyl-2-hydroxy-3,3-dimethylbuyrate
-
(2RS)-adenosyl-2-hydroxy-4-methoxybutyrate
-
(2RS)-adenosyl-3,3-dimethyl-2-hydroxy-4-methoxybutyrate
-
(2S)-adenosyl-2-L-amino-3,3-dimethylbutanoate
-
(3E)-3-[2-[(cyclohexylamino)(oxo)acetyl]hydrazinylidene]-N-[(4-methoxyphenyl)methyl]butanamide
-
(3Z)-3-[2-[3-([(E)-[(4-methoxyphenyl)methylidene]amino]oxy)prop-1-en-2-yl]hydrazinylidene]-1,3-dihydro-2H-indol-2-one
-
(4R)-2-[(2-anilinoprop-2-en-1-yl)sulfanyl]-4-(4-methoxyphenyl)-6-oxo-1,4,5,6-tetrahydropyridine-3-carbonitrile
-
(5-(4-fluorophenylsulfonyl)-3-phenyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridin-1-yl)(phenyl)methanone
77.0% inhibition at 0.1 mM
(5-(4-nitrophenylsulfonyl)-3-phenyl-4,5,6,7-tetrahydro-1Hpyrazolo[4,3-c]pyridin-1-yl)(phenyl)methanone
39.7% inhibition at 0.1 mM
(5-methoxy-2-[[2-nitro-4-(trifluoromethyl)benzene-1-sulfonyl]carbamoyl]-1H-indol-1-yl)acetic acid
-
(5-methoxy-2-[[4-(trifluoromethyl)benzene-1-sulfonyl]carbamoyl]-1H-indol-1-yl)acetic acid
-
(R)-pantoate
-
substrate inhibition
(Z)-N'-(3-(4-oxo-2-thioxo-5-(3,4,5-trimethoxybenzylidene)thiazolidin-3-yl)propanoyl)-1-naphthohydrazide
-
-
(Z)-N'-(3-(4-oxo-2-thioxo-5-(3,4,5-trimethoxybenzylidene)thiazolidin-3-yl)propanoyl)benzohydrazide
-
-
(Z)-N'-(3-(4-oxo-2-thioxo-5-(3,4,5-trimethoxybenzylidene)thiazolidin-3-yl)propanoyl)isonicotinohydrazide
-
-
(Z)-N'-(3-(4-oxo-2-thioxo-5-(3,4,5-trimethoxybenzylidene)thiazolidin-3-yl)propanoyl)nicotinohydrazide
-
-
(Z)-N'-(3-(5-(4-(benzyloxy)benzylidene)-4-oxo-2-thioxothiazolidin-3-yl)propanoyl)-1-naphthohydrazide
-
-
(Z)-N'-(3-(5-(4-(benzyloxy)benzylidene)-4-oxo-2-thioxothiazolidin-3-yl)propanoyl)benzohydrazide
-
-
(Z)-N'-(3-(5-(4-(benzyloxy)benzylidene)-4-oxo-2-thioxothiazolidin-3-yl)propanoyl)isonicotinohydrazide
-
-
(Z)-N'-(3-(5-(4-(benzyloxy)benzylidene)-4-oxo-2-thioxothiazolidin-3-yl)propanoyl)nicotinohydrazide
-
-
(Z)-N'-(3-(5-(4-chlorobenzylidene)-4-oxo-2-thioxothiazolidin-3-yl)propanoyl)-1-naphthohydrazide
-
-
(Z)-N'-(3-(5-(4-chlorobenzylidene)-4-oxo-2-thioxothiazolidin-3-yl)propanoyl)benzohydrazide
-
-
(Z)-N'-(3-(5-(4-chlorobenzylidene)-4-oxo-2-thioxothiazolidin-3-yl)propanoyl)isonicotinohydrazide
-
-
(Z)-N'-(3-(5-(4-chlorobenzylidene)-4-oxo-2-thioxothiazolidin-3-yl)propanoyl)nicotinohydrazide
-
-
(Z)-N'-(3-(5-(4-nitrobenzylidene)-4-oxo-2-thioxothiazolidin-3-yl)-propanoyl)-1-naphthohydrazide
-
-
(Z)-N'-(3-(5-(4-nitrobenzylidene)-4-oxo-2-thioxothiazolidin-3-yl)-propanoyl)benzohydrazide
-
-
(Z)-N'-(3-(5-(4-nitrobenzylidene)-4-oxo-2-thioxothiazolidin-3-yl)-propanoyl)isonicotinohydrazide
-
-
(Z)-N'-(3-(5-(4-nitrobenzylidene)-4-oxo-2-thioxothiazolidin-3-yl)-propanoyl)nicotinohydrazide
-
-
(Z)-N'-(3-(5-(benzo[d][1,3]dioxol-5-ylmethylene)-4-oxo-2-thioxothiazolidin-3-yl)propanoyl)-1-naphthohydrazide
-
(Z)-N'-(3-(5-(benzo[d][1,3]dioxol-5-ylmethylene)-4-oxo-2-thioxothiazolidin-3-yl)propanoyl)benzohydrazide
-
(Z)-N'-(3-(5-(benzo[d][1,3]dioxol-5-ylmethylene)-4-oxo-2-thioxothiazolidin-3-yl)propanoyl)isonicotinohydrazide
-
(Z)-N'-(3-(5-(benzo[d][1,3]dioxol-5-ylmethylene)-4-oxo-2-thioxothiazolidin-3-yl)propanoyl)nicotinohydrazide
-
1-(4-(1-(cyclohexanecarbonyl)-3-phenyl-6,7-dihydro-1Hpyrazolo[4,3-c]pyridin-5(4H)-ylsulfonyl)phenyl)ethanone
39.2% inhibition at 0.1 mM
1-(4-(1-benzoyl-3-phenyl-6,7-dihydro-1H-pyrazolo[4,3-c]pyridin-5(4H)-ylsulfonyl)phenyl)ethanone
78.5% inhibition at 0.1 mM
1-(cyclohexanecarbonyl)-3-phenyl-N-p-tolyl-6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-5(4H)-carbothioamide
50.5% inhibition at 0.1 mM
1-(cyclohexanecarbonyl)-3-phenyl-N-p-tolyl-6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-5(4H)-carboxamide
40.8% inhibition at 0.1 mM
1-(cyclohexanecarbonyl)-N-(4-ethoxyphenyl)-3-phenyl-6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-5(4H)-carboxamide
48.5% inhibition at 0.1 mM
1-(cyclohexanecarbonyl)-N-(4-fluorophenyl)-3-phenyl-6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-5(4H)-carbothioamide
49.2% inhibition at 0.1 mM
1-(cyclohexanecarbonyl)-N-(4-methoxyphenyl)-3-phenyl-6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-5(4H)-carbothioamide
50.6% inhibition at 0.1 mM
1-(cyclohexanecarbonyl)-N-(4-methoxyphenyl)-3-phenyl-6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-5(4H)-carboxamide
38.7% inhibition at 0.1 mM
1-(cyclohexanecarbonyl)-N-(4-nitrophenyl)-3-phenyl-6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-5(4H)-carbothioamide
47.3% inhibition at 0.1 mM
1-(cyclohexanecarbonyl)-N-(naphthalen-1-yl)-3-phenyl-6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-5(4H)-carboxamide
50.9% inhibition at 0.1 mM
1-(yclohexanecarbonyl)-N-(4-nitrophenyl)-3-phenyl-6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-5(4H)-carboxamide
50.8% inhibition at 0.1 mM
1-benzofuran-2-carboxylic acid
competitive with respect to both ATP and pantoate
1-benzoyl-3-phenyl-N-p-tolyl-6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-5(4H)-carbothioamide
23.9% inhibition at 0.1 mM
1-benzoyl-3-phenyl-N-p-tolyl-6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-5(4H)-carboxamide
49.4% inhibition at 0.1 mM
1-benzoyl-N-(4-bromophenyl)-3-phenyl-6,7-dihydro-1Hpyrazolo[4,3-c]pyridine-5(4H)-carboxamide
60.6% inhibition at 0.1 mM
1-benzoyl-N-(4-chlorophenyl)-3-phenyl-6,7-dihydro-1Hpyrazolo[4,3-c]pyridine-5(4H)-carbothioamide
37.7% inhibition at 0.1 mM
1-benzoyl-N-(4-chlorophenyl)-3-phenyl-6,7-dihydro-1Hpyrazolo[4,3-c]pyridine-5(4H)-carboxamide
40.2% inhibition at 0.1 mM
1-benzoyl-N-(4-ethoxyphenyl)-3-phenyl-6,7-dihydro-1Hpyrazolo[4,3-c] pyridine-5(4H)-carboxamide
47.2% inhibition at 0.1 mM
1-benzoyl-N-(4-fluorophenyl)-3-phenyl-6,7-dihydro-1Hpyrazolo[4,3-c]pyridine-5(4H)-carbothioamide
43.5% inhibition at 0.1 mM
1-benzoyl-N-(4-methoxyphenyl)-3-phenyl-6,7-dihydro-1Hpyrazolo[4,3-c]pyridine-5(4H)-carbothioamide
10.2% inhibition at 0.1 mM
1-benzoyl-N-(4-nitrophenyl)-3-phenyl-6,7-dihydro-1Hpyrazolo[4,3-c]pyridine-5(4H)-carboxamide
95.7% inhibition at 0.1 mM
1-benzoyl-N-(naphthalen-1-yl)-3-phenyl-6,7-dihydro-1Hpyrazolo[4,3-c]pyridine-5(4H)-carboxamide
89.8% inhibition at 0.1 mM
1-benzoyl-N-benzyl-3-phenyl-6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-5(4H)-carbothioamide
52.1% inhibition at 0.1 mM
1-benzoyl-N-benzyl-3-phenyl-6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-5(4H)-carboxamide
46.2% inhibition at 0.1 mM
1-benzoyl-N-isopropyl-3-phenyl-6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-5(4H)-carboxamide
40.9% inhibition at 0.1 mM
2,3-Diaminopropanoate
-
slight
2,6-dimethyl-N-(thiophen-2-ylmethyl)-2H,3H-imidazo[1,2-a]pyridine-3-carboxamide
GSK358607A, MIC value is 190 nM
2-(4-bromophenyl)-2-oxoethyl 2-[4-[2-(4-bromophenyl)-2-oxoethoxy]-4-oxobutanamido]benzoate
-
2-(5-nitrofuran-2-carboxamido)-6-(4-nitrophenylcarbamothioyl)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
-
2-(5-nitrofuran-2-carboxamido)-6-(4-nitrophenylsulfonyl)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
-
2-hydroxybutanoate
-
slight
2-Hydroxypropanoate
-
slight
2-methyl-5-methoxyindole
binding mode with the 2-CH3 group facing the pantoate pocket
2-methyl-N'-(3,4,5-trimethoxybenzylidene)benzo[d]imidazo[2,1-b]thiazole-3-carbohydrazide
-
2-methyl-N'-(3,4,5-trimethoxybenzylidene)imidazo[1,2-a]pyridine-3-carbohydrazide
-
2-methyl-N'-(3-nitrobenzoyl)imidazo[1,2-a]pyridine-3-carbohydrazide
-
2-methyl-N'-(4-(trifluoromethyl)benzylidene)benzo[d]imidazo[2,1-b]thiazole-3-carbohydrazide
-
2-methyl-N'-(4-(trifluoromethyl)benzylidene)imidazo[1,2-a]pyridine-3-carbohydrazide
-
2-methyl-N'-(4-methylbenzoyl)benzo[d]imidazo[2,1-b]thiazole-3-carbohydrazide
-
2-methyl-N'-(4-methylbenzoyl)imidazo[1,2-a]pyridine-3-carbohydrazide
-
2-methyl-N'-(4-methylbenzylidene)imidazo[1,2-a]pyridine-3-carbohydrazide
-
2-methyl-N'-(4-nitrobenzylidene)imidazo[1,2-a]pyridine-3-carbohydrazide
-
2-methyl-N'-(4-phenoxybenzoyl)benzo[d]imidazo[2,1-b]thiazole-3-carbohydrazide
-
2-methyl-N'-(4-phenoxybenzoyl)imidazo[1,2-a]pyridine-3-carbohydrazide
-
2-methyl-N-(3-(trifluoromethyl)phenyl)imidazo[1,2-a]pyridine-3-carboxamide
-
2-methyl-N-(pyridin-2-yl)imidazo[1,2-a]pyridine-3-carboxamide
-
2-methyl-N-phenethylimidazo[1,2-a]pyridine-3-carboxamide
-
2-methyl-N-phenylbenzo[d]imidazo[2,1-b]thiazole-3-carboxamide
-
2-methyl-N-phenylimidazo[1,2-a]pyridine-3-carboxamide
-
2-[(2Z)-2-[(5-8[(benzenesulfonyl)amino]methyl]furan-2-yl)methylidene]hydrazinyl]-N-(4-ethoxyphenyl)-2-oxoacetamide
-
3,3-dimethyl-2-oxobutyric acid 5-(6-aminopurin-9-yl)-3,4-dihydroxytetrahydrofuran-2-ylmethyl ester
-
3-(biphenyl-4-yl)-4-cyano-5-(ethylsulfanyl)-1-methyl-1H-pyrrole-2-carboxylic acid
-
3-hydroxybutanoate
-
slight
3-hydroxypropanoate
-
slight
3-[(R)-[1-(2-methoxyethyl)-1H-tetrazol-5-yl][4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]methyl]-8-methylquinolin-2(1H)-one
-
3-[[4-(1,3-benzothiazol-2-yl)piperazin-1-yl][1-(2-methoxyethyl)-1H-tetrazol-5-yl]methyl]-8-methyl-3,4-dihydroquinolin-2(1H)-one
-
4-(2-{3-[(1E,3E)-hexa-1,3,5-trien-1-yl]phenyl}hydrazinyl)-4-oxobutanoic acid
-
27% inhibition
4-(4-chlorobenzoyl)-3-hydroxy-1-[3-(1H-imidazol-1-yl)propyl]-5-[(2R)-oxolan-2-yl]-1,5-dihydro-2H-pyrrol-2-one
-
4-Amino-3-hydroxybutanoate
4-cyano-3-(4'-cyanobiphenyl-4-yl)-1-methyl-5-propyl-1H-pyrrole-2-carboxylic acid
-
4-[(4-[[(5-tert-butyl-4,5,6,7-tetrahydro-1,2-benzisoxazol-3-yl)carbonyl]amino]-1H-pyrazol-1-yl)methyl]benzoic acid
0.1 mM, 99% inhibition
5-methoxyindole
competitive with respect to ATP
5-tert-butyl-4,5,6,7-tetrahydro-1,2-benzisoxazole-3-carboxylic acid
0.1 mM, 12% inhibition
5-tert-butyl-N-(1-[4-[(2-phenylethyl)carbamoyl]benzyl]-1H-pyrazol-4-yl)-4,5,6,7-tetrahydro-1,2-benzisoxazole-3-carboxamide
0.1 mM, 78% inhibition
5-tert-butyl-N-1H-pyrazol-4-yl-4,5,6,7-tetrahydro-1,2-benzisoxazole-3-carboxamide
0.1 mM, 43% inhibition
5-tert-butyl-N-pyrazol-4-yl-4,5,6,7-tetrahydrobenzo[d]isoxazole-3-carboxamide derivatives
silico molecular design, synthesis, and inhibitory activity, overview
5-tert-butyl-N-[1-(2,4,6-trichlorophenyl)-1H-pyrazol-4-yl]-4,5,6,7-tetrahydro-1,2-benzisoxazole-3-carboxamide
0.1 mM, 17% inhibition
5-tert-butyl-N-[1-(2,4-difluorobenzyl)-1H-pyrazol-4-yl]-4,5,6,7-tetrahydro-1,2-benzisoxazole-3-carboxamide
0.1 mM, 100% inhibition
5-tert-butyl-N-[1-(2-iodobenzyl)-1H-pyrazol-4-yl]-4,5,6,7-tetrahydro-1,2-benzisoxazole-3-carboxamide
0.1 mM, 84% inhibition
5-tert-butyl-N-[1-(2-methylbenzyl)-1H-pyrazol-4-yl]-4,5,6,7-tetrahydro-1,2-benzisoxazole-3-carboxamide
0.1 mM, 89% inhibition
5-tert-butyl-N-[1-(4-chlorobenzyl)-1H-pyrazol-4-yl]-4,5,6,7-tetrahydro-1,2-benzisoxazole-3-carboxamide
0.1 mM, 98% inhibition
5-tert-butyl-N-[1-(4-fluorobenzyl)-1H-pyrazol-4-yl]-4,5,6,7-tetrahydro-1,2-benzisoxazole-3-carboxamide
0.1 mM, 98% inhibition
5-tert-butyl-N-[1-(naphthalen-1-ylmethyl)-1H-pyrazol-4-yl]-4,5,6,7-tetrahydro-1,2-benzoxazole-3-carboxamide
-
5-tert-butyl-N-[1-(naphthalen-2-ylmethyl)-1H-pyrazol-4-yl]-4,5,6,7-tetrahydro-1,2-benzisoxazole-3-carboxamide
0.1 mM, 97% inhibition
5-tert-butyl-N-[4-carbamoyl-3-(4-methoxybenzyl)isoxazol-5-yl]-4,5,6,7-tetrahydro-1,2-benzisoxazole-3-carboxamide
0.1 mM, 79% inhibition
6-(4-acetylphenylsulfonyl)-2-(5-nitrofuran-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
-
6-(4-acetylphenylsulfonyl)-2-(5-nitrothiophene-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
-
6-(4-bromophenylsulfonyl)-2-(5-nitrofuran-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
-
6-(4-bromophenylsulfonyl)-2-(5-nitrothiophene-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
-
6-(4-chlorophenylcarbamothioyl)-2-(5-nitrofuran-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
-
6-(4-chlorophenylcarbamothioyl)-2-(5-nitrothiophene-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
-
6-(4-chlorophenylcarbamoyl)-2-(5-nitrofuran-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
-
6-(4-chlorophenylcarbamoyl)-2-(5-nitrothiophene-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
-
6-(4-fluorophenylcarbamothioyl)-2-(5-nitrofuran-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
-
6-(4-fluorophenylcarbamothioyl)-2-(5-nitrothiophene-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
-
6-(4-fluorophenylsulfonyl)-2-(5-nitrofuran-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
-
6-(4-fluorophenylsulfonyl)-2-(5-nitrothiophene-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
-
6-(4-methoxyphenylcarbamoyl)-2-(5-nitrofuran-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
-
6-(4-methoxyphenylcarbamoyl)-2-(5-nitrothiophene-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
-
6-(4-methoxyphenylsulfonyl)-2-(5-nitrofuran-2-arboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
-
6-(4-methoxyphenylsulfonyl)-2-(5-nitrothiophene-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
-
6-(4-nitrophenylcarbamothioyl)-2-(5-nitrothiophene-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
-
6-(4-nitrophenylcarbamoyl)-2-(5-nitrofuran-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
-
6-(4-nitrophenylcarbamoyl)-2-(5-nitrothiophene-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
-
6-(4-nitrophenylsulfonyl)-2-(5-nitrothiophene-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
-
6-(benzylcarbamothioyl)-2-(5-nitrofuran-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
-
6-(benzylcarbamothioyl)-2-(5-nitrothiophene-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
-
6-(benzylcarbamoyl)-2-(5-nitrofuran-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
-
6-(benzylcarbamoyl)-2-(5-nitrothiophene-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
-
6-acetyl-2-(thiophene-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
SID 92097880, MIC values is 0.0032 mM
6-aminohexanoate
-
slight
6-methyl-N'-(3,4,5-trimethoxybenzylidene)imidazo[2,1-b]thiazole-5-carbohydrazide
-
6-methyl-N'-(4-(trifluoromethyl)benzylidene)imidazo[2,1-b]thiazole-5-carbohydrazide
-
6-methyl-N'-(4-methylbenzoyl)imidazo[2,1-b]thiazole-5-carbohydrazide
-
6-methyl-N'-(4-phenoxybenzoyl)imidazo[2,1-b]thiazole-5-carbohydrazide
-
6-methyl-N-phenylimidazo[2,1-b]thiazole-5-carboxamide
-
7-[(2S)-2-hydroxy-3-(4-methoxyphenoxy)propyl]-3-methyl-8-[[(2Z)-2-(2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazinyl]methyl]-3,7-dihydro-1H-purine-2,6-dione
-
7-[(R)-[4-[(2H-1,3-benzodioxol-5-yl)methyl]piperazin-1-yl][4-(2-methoxyethyl)-4H-1,2,4-triazol-3-yl]methyl]-7,8-dihydro-2H-[1,3]dioxolo[4,5-g]quinolin-6(5H)-one
-
aspartate
-
24% inhibition at 1 mM
benzyl (1-[[1-hydrazinyl-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl)carbamate
-
cyclohexyl(3-phenyl-5-(thiophen-2-ylsulfonyl)-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridin-1-yl)methanone
52.0% inhibition at 0.1 mM
cyclohexyl(3-phenyl-5-tosyl-4,5,6,7-tetrahydro-1Hpyrazolo[4,3-c]pyridin-1-yl)methanone
41.6% inhibition at 0.1 mM
cyclohexyl(5-(4-fluorophenylsulfonyl)-3-phenyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridin-1-yl)methanone
46.8% inhibition at 0.1 mM
cyclohexyl(5-(4-nitrophenylsulfonyl)-3-phenyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridin-1-yl)methanone
50.2% inhibition at 0.1 mM
ethyl 2-[[(2,4,6-trioxotetrahydropyrimidin-5(2H)-ylidene)methyl]amino]-1,3-benzothiazole-6-carboxylate
-
gluconate
-
32% inhibition at 1 mM
glycolate
-
30% inhibition at 1 mM
Mercaptoethanolamine
-
weak
methyl 4-(2-[[(naphthalen-1-yl)oxy]acetyl]hydrazinesulfonyl)benzoate
-
methyl 4-[(4-[[(5-tert-butyl-4,5,6,7-tetrahydro-1,2-benzisoxazol-3-yl)carbonyl]amino]-1H-pyrazol-1-yl)methyl]benzoate
0.1 mM, 100% inhibition
methyl 5-amino-3-(benzyloxy)-1H-indole-2-carboxylate
-
methyl 6-amino-4-(benzyloxy)-1H-indole-2-carboxylate
-
69% inhibition
methylmalonate
-
38% inhibition at 1 mM
Mg2+
-
inhibition above 10 mM
Mn2+
-
inhibition above 5 mM
N'-(1-naphthoyl)-2-methylbenzo[d]imidazo[2,1-b]thiazole-3-carbohydrazide
-
N'-(1-naphthoyl)-2-methylimidazo[1,2-a]pyridine-3-carbohydrazide
-
N'-(1-naphthoyl)-6-methylimidazo[2,1-b]thiazole-5-carbohydrazide
-
N'-(2,4-dichlorobenzoyl)-2-methylimidazo[1,2-a]pyridine-3-carbohydrazide
-
N'-(2-methoxybenzoyl)-2-methylimidazo[1,2-a]pyridine-3-carbohydrazide
-
N'-(3,5-dinitrobenzoyl)-2-methylimidazo[1,2-a]pyridine-3-carbohydrazide
-
N'-(4-(benzyloxy)benzylidene)-2-methylimidazo[1,2-a]pyridine-3-carbohydrazide
-
N'-(4-(dimethylamino)benzylidene)-2-methylbenzo[d]imidazo[2,1-b]thiazole-3-carbohydrazide
-
N'-(4-(dimethylamino)benzylidene)-6-methylimidazo[2,1-b]thiazole-5-carbohydrazide
-
N'-(4-bromobenzylidene)-2-methylbenzo[d]imidazo[2,1-b]thiazole-3-carbohydrazide
-
N'-(4-bromobenzylidene)-2-methylimidazo[1,2-a]pyridine-3-carbohydrazide
-
N'-(4-bromobenzylidene)-6-methylimidazo[2,1-b]thiazole-5-carbohydrazide
-
N'-(4-fluorobenzylidene)-2-methylimidazo[1,2-a]pyridine-3-carbohydrazide
-
N'-(4-hydroxybenzylidene)-2-methylimidazo[1,2-a]pyridine-3-carbohydrazide
-
N'-(4-methoxybenzylidene)-2-methylimidazo[1,2-a]pyridine-3-carbohydrazide
-
N'-(cyclohexanecarbonyl)-2-methylbenzo[d]imidazo[2,1-b]thiazole-3-carbohydrazide
-
N'-(cyclohexanecarbonyl)-2-methylimidazo[1,2-a]pyridine-3-carbohydrazide
-
N'-(cyclohexanecarbonyl)-6-methylimidazo[2,1-b]thiazole-5-carbohydrazide
-
N'-(furan-2-carbonyl)-2-methylimidazo[1,2-a]pyridine-3-carbohydrazide
-
N'-([[5-(4-hydroxyphenyl)-4-methyl-4H-1,2,4-triazol-3-yl]sulfanyl]acetyl)pyridine-4-carbohydrazide
-
N'-benzoyl-2-methylbenzo[d]imidazo[2,1-b]thiazole-3-carbohydrazide
-
N'-benzoyl-2-methylimidazo[1,2-a]pyridine-3-carbohydrazide
-
N'-benzoyl-6-methylimidazo[2,1-b]thiazole-5-carbohydrazide
-
N'-benzylidene-2-methylbenzo[d]imidazo[2,1-b]thiazole-3-carbohydrazide
-
N'-benzylidene-2-methylimidazo[1,2-a]pyridine-3-carbohydrazide
-
N'-benzylidene-6-methylimidazo[2,1-b]thiazole-5-carbohydrazide
-
N-(1-benzyl-1H-pyrazol-4-yl)-5-tert-butyl-4,5,6,7-tetrahydro-1,2-benzisoxazole-3-carboxamide
0.1 mM, 100% inhibition
N-(2,5-dibromophenyl)-2-hydroxybenzamide
-
N-(3-benzamidobenzoyl)tryptophan
-
N-(4-acetylphenyl)-1-(cyclohexanecarbonyl)-3-phenyl-6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-5(4H)-carboxamide
51.4% inhibition at 0.1 mM
N-(4-acetylphenyl)-1-benzoyl-3-phenyl-6,7-dihydro-1Hpyrazolo[4,3-c] pyridine-5(4H)-carboxamide
43.7% inhibition at 0.1 mM
N-(4-bromophenyl)-1-(cyclohexanecarbonyl)-3-phenyl-6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-5(4H)-carboxamide
50.5% inhibition at 0.1 mM
N-(4-bromophenyl)-2-methylbenzo[d]imidazo[2,1-b]thiazole-3-carboxamide
-
N-(4-bromophenyl)-2-methylimidazo[1,2-a]pyridine-3-carboxamide
-
N-(4-bromophenyl)-6-methylimidazo[2,1-b]thiazole-5-carboxamide
-
N-(4-chlorophenyl)-1-(cyclohexanecarbonyl)-3-phenyl-6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-5(4H)-carbothioamide
56.3% inhibition at 0.1 mM
N-(4-chlorophenyl)-1-(cyclohexanecarbonyl)-3-phenyl-6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-5(4H)-carboxamide
54.7% inhibition at 0.1 mM
N-(4-chlorophenyl)-2-methylimidazo[1,2-a]pyridine-3-carboxamide
-
N-(4-ethoxyphenyl)-2-methylbenzo[d]imidazo[2,1-b]thiazole-3-carboxamide
-
N-(4-ethoxyphenyl)-2-methylimidazo[1,2-a]pyridine-3-carboxamide
-
N-(4-methoxyphenyl)-6-methylimidazo[2,1-b]thiazole-5-carboxamide
-
N-(furan-2-ylmethyl)-2-methylimidazo[1,2-a]pyridine-3-carboxamide
-
N-allyl-1-benzoyl-3-phenyl-6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-5(4H)-carbothioamide
41.7% inhibition at 0.1 mM
N-benzyl-1-(cyclohexanecarbonyl)-3-phenyl-6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-5(4H)-carbothioamide
51.4% inhibition at 0.1 mM
N-benzyl-1-(cyclohexanecarbonyl)-3-phenyl-6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-5(4H)-carboxamide
49.1% inhibition at 0.1 mM
N-benzyl-2-methylbenzo[d]imidazo[2,1-b]thiazole-3-carboxamide
-
N-benzyl-2-methylimidazo[1,2-a]pyridine-3-carboxamide
-
N-benzyl-6-methylimidazo[2,1-b]thiazole-5-carboxamide
-
N-cyclohexyl-2-methylbenzo[d]imidazo[2,1-b]thiazole-3-carboxamide
-
N-cyclohexyl-2-methylimidazo[1,2-a]pyridine-3-carboxamide
-
N-cyclohexyl-6-methylimidazo[2,1-b]thiazole-5-carboxamide
-
N-[1-(2,4-dichlorobenzyl)-1H-pyrazol-4-yl]-4,5,6,7-tetrahydro-1,2-benzisoxazole-3-carboxamide
0.1 mM, 18% inhibition
N-[1-(2-bromobenzyl)-1H-pyrazol-4-yl]-5-tert-butyl-4,5,6,7-tetrahydro-1,2-benzisoxazole-3-carboxamide
0.1 mM, 94% inhibition
N-[1-[4-(benzylcarbamoyl)benzyl]-1H-pyrazol-4-yl]-5-tert-butyl-4,5,6,7-tetrahydro-1,2-benzisoxazole-3-carboxamide
0.1 mM, 82% inhibition
N-[2-(4-methylbenzamido)benzoyl]-D-tryptophan
-
N-[2-(cyclohexylamino)-1-(3,4-dihydroxyphenyl)-2-oxoethyl]-2-([2-[(5-methyl-1,2-oxazol-3-yl)amino]-2-oxoethyl]sulfanyl)-N-phenylacetamide
-
N-[3-(2-chlorobenzamido)benzoyl]tryptophan
-
N-[3-(2-fluorobenzamido)benzoyl]tryptophan
-
N-[3-(3-chlorobenzamido)benzoyl]tryptophan
-
N-[3-(3-nitrobenzamido)benzoyl]tryptophan
-
N-[3-(4-chlorobenzamido)benzoyl]tryptophan
-
N-[3-(4-fluorobenzamido)benzoyl]tryptophan
-
N-[3-(4-nitrobenzamido)benzoyl]tryptophan
-
N-[3-(4-tert-butylbenzamido)benzoyl]tryptophan
-
N-[3-([[(furan-2-yl)oxy]carbonyl]amino)benzoyl]tryptophan
-
N-[3-[(cyclohexanecarbonyl)amino]benzoyl]tryptophan
-
N-[3-[(cyclopentanecarbonyl)amino]benzoyl]tryptophan
-
N-[3-[(pyrazine-2-carbonyl)amino]benzoyl]tryptophan
-
N-[3-[(thiophene-2-carbonyl)amino]benzoyl]tryptophan
-
N-[3-[2-(4-methoxyphenyl)acetamido]benzoyl]tryptophan
-
N-[3-[2-(trifluoromethyl)benzamido]benzoyl]tryptophan
-
N-[4-[(2-[(2E)-2-[(3-methoxyphenyl)methylidene]hydrazinyl]-2-oxoethyl)(2-phenylethyl)sulfamoyl]phenyl]acetamide
-
N-[7-[(2S)-3-(4-chlorophenoxy)-2-hydroxypropyl]-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl]-D-alanine
-
N1-[(furan-2-yl)methyl]-N2-([3-[(3-[[(furan-2-yl)methyl]amino]-2,3-dioxopropyl)amino]phenyl]methyl)ethanediamide
-
pantothenate
-
product inhibition
phenyl(3-phenyl-5-(thiophen-2-ylsulfonyl)-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridin-1-yl)methanone
48.7% inhibition at 0.1 mM
phenyl(3-phenyl-5-tosyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridin-1-yl)methanone
9.0% inhibition at 0.1 mM
tert-butyl 4-[(4-[[(5-tert-butyl-4,5,6,7-tetrahydro-1,2-benzisoxazol-3-yl)carbonyl]amino]-1H-pyrazol-1-yl)methyl]benzoate
0.1 mM, 79% inhibition
[2-[(1-benzofuran-2-sulfonyl)carbamoyl]-5-methoxy-1H-indol-1-yl]acetic acid
-
[2-[(1-benzofuran-2-ylsulfonyl)carbamoyl]-5-methyl-1H-inden-1-yl]acetic acid
-
[2-[(4-acetamidobenzene-1-sulfonyl)carbamoyl]-5-methoxy-1H-indol-1-yl]acetic acid
-
[2-[(4-acetylpiperazine-1-sulfonyl)carbamoyl]-5-methoxy-1H-indol-1-yl]acetic acid
-
[2-[(4-tert-butylbenzene-1-sulfonyl)carbamoyl]-5-methoxy-1H-indol-1-yl]acetic acid
-
[2-[(5-acetamido-1,3,4-thiadiazole-2-sulfonyl)carbamoyl]-5-methoxy-1H-indol-1-yl]acetic acid
-
[4-[2-(3,4-dihydroxyphenyl)-4-phenyl-1H-imidazol-5-yl]phenyl](phenyl)methanone
-
[5-methoxy-2-[(4-methoxybenzene-1-sulfonyl)carbamoyl]-1H-indol-1-yl]acetic acid
-
[5-methoxy-2-[(4-methylbenzene-1-sulfonyl)carbamoyl]-1H-indol-1-yl]acetic acid
-
[5-methoxy-2-[(5-methylpyridine-2-sulfonyl)carbamoyl]-1H-indol-1-yl]acetic acid
-
[5-methoxy-2-[(morpholine-4-sulfonyl)carbamoyl]-1H-indol-1-yl]acetic acid
-
[5-methoxy-2-[(naphthalene-2-sulfonyl)carbamoyl]-1H-indol-1-yl]acetic acid
-
4-Amino-3-hydroxybutanoate
-
32% inhibition at 1 mM
4-Amino-3-hydroxybutanoate
-
-
4-aminobutanoate
-
27% inhibition at 1 mM
5-Aminopentanoate
-
slight
actinomycin D
-
-
ethambutol
-
Fe2+
-
slight
iodoacetate
-
-
isoniazid
-
L-Val
-
-
nafronyl oxalate
-
competitive inhibitor
Ni2+
-
slight
Pb2+
-
slight
taurine
-
52% inhibition at 1 mM
additional information
development, synthesis and evaluation of tetrahydrothieno[2,3-c]pyridine-3-carboxamide-based inhibitors, computational molecular modeling, overview
-
additional information
-
development, synthesis and evaluation of tetrahydrothieno[2,3-c]pyridine-3-carboxamide-based inhibitors, computational molecular modeling, overview
-
additional information
synthesis and evaluation of 3-phenyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine derivatives as pantothenate synthetase inhibitors, overview. No inhibition by isoniazid and ethambutol
-
additional information
-
synthesis and evaluation of 3-phenyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine derivatives as pantothenate synthetase inhibitors, overview. No inhibition by isoniazid and ethambutol
-
additional information
evaluation of 3-biphenyl-4-cyanopyrrole-2-carboxylic acids as enzyme inhibitors, overview
-
additional information
-
evaluation of 3-biphenyl-4-cyanopyrrole-2-carboxylic acids as enzyme inhibitors, overview
-
additional information
usage of the crystal structure of mycobacterial pantothenate synthetase bound with 2-(2-(benzofuran-2-ylsulfonylcarbamoyl)-5-methoxy-1H-indol-1-yl) acetic acid inhibitor for virtual screening of an antitubercular compound database, identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as inhibitors of Mycobacterium tuberculosis pantothenate synthetase, synthesis of 30 derivatives and evaluation as inhibitors, inhibition study of in vitro anti-TB activities against replicative and non-replicative MTB, in vivo activity using Mycobacterium marinum infected Zebra fish, and cytotoxicity against RAW 264.7 cell line, overview
-
additional information
-
usage of the crystal structure of mycobacterial pantothenate synthetase bound with 2-(2-(benzofuran-2-ylsulfonylcarbamoyl)-5-methoxy-1H-indol-1-yl) acetic acid inhibitor for virtual screening of an antitubercular compound database, identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as inhibitors of Mycobacterium tuberculosis pantothenate synthetase, synthesis of 30 derivatives and evaluation as inhibitors, inhibition study of in vitro anti-TB activities against replicative and non-replicative MTB, in vivo activity using Mycobacterium marinum infected Zebra fish, and cytotoxicity against RAW 264.7 cell line, overview
-
additional information
design of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives from earlier reported imidazo[1,2-a]pyridine based Mycobacterium tuberculosis (MTB) pantothenate synthetase inhibitors, evaluation of thirty compounds as enzyme inhibitors and anti-tuberculosis agents, inhibition study of in vitro anti-TB activities against replicative and non-replicative MTB, in vivo activity using Mycobacterium marinum infected Zebra fish, and cytotoxicity against RAW 264.7 cell line, overview. No inhibition by amoxicillin
-
additional information
-
design of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives from earlier reported imidazo[1,2-a]pyridine based Mycobacterium tuberculosis (MTB) pantothenate synthetase inhibitors, evaluation of thirty compounds as enzyme inhibitors and anti-tuberculosis agents, inhibition study of in vitro anti-TB activities against replicative and non-replicative MTB, in vivo activity using Mycobacterium marinum infected Zebra fish, and cytotoxicity against RAW 264.7 cell line, overview. No inhibition by amoxicillin
-
additional information
construction of inhibitor molecules with optimized binding efficiencies, the stepwise growing of an indole fragment leads to the generation of a lead compound, analysis of the binding kinetics of the compounds, overview
-
additional information
-
construction of inhibitor molecules with optimized binding efficiencies, the stepwise growing of an indole fragment leads to the generation of a lead compound, analysis of the binding kinetics of the compounds, overview
-
additional information
using energy-based pharmacophore modeling and in vitro screening, structure-guided design (PDB ID 1N2I)and synthesis of thiazolidine derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors from a rational inhibitor design approach, overview
-
additional information
-
using energy-based pharmacophore modeling and in vitro screening, structure-guided design (PDB ID 1N2I)and synthesis of thiazolidine derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors from a rational inhibitor design approach, overview
-
additional information
inhibitor docking study, molecular docking of a set of pyrazole-based inhibitors to the active site of the enzyme, the docking solutions are post-processed using the MM-PB(GB)SA method and molecular dynamic simulations in order to analyze and validate the two previously proposed binding modes. Both the MM-PBSA and MM-GBSA are able to discriminate between active and inactive compounds. The pharmacophore-based scoring method proves efficient in discriminating the active compounds from inactives. Method development for screening of potential inhibitors of the enzyme from commercially available databases
-
additional information
-
inhibitor docking study, molecular docking of a set of pyrazole-based inhibitors to the active site of the enzyme, the docking solutions are post-processed using the MM-PB(GB)SA method and molecular dynamic simulations in order to analyze and validate the two previously proposed binding modes. Both the MM-PBSA and MM-GBSA are able to discriminate between active and inactive compounds. The pharmacophore-based scoring method proves efficient in discriminating the active compounds from inactives. Method development for screening of potential inhibitors of the enzyme from commercially available databases
-
additional information
development of inhibitors active against the enzyme using energy based pharmacophore modeling of the available protein-inhibitor complex (3IVX) and virtual screening of a large commercial library. The e-pharmacophore model consists of a ring aromatic, negative ionizable, and acceptor sites. Inhibitor structure optimization, molecular docking. Determinations of MIC values and cytotoxicity against HEK-293 cells for the inhibitors, overview
-
additional information
-
development of inhibitors active against the enzyme using energy based pharmacophore modeling of the available protein-inhibitor complex (3IVX) and virtual screening of a large commercial library. The e-pharmacophore model consists of a ring aromatic, negative ionizable, and acceptor sites. Inhibitor structure optimization, molecular docking. Determinations of MIC values and cytotoxicity against HEK-293 cells for the inhibitors, overview
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.00892
(3E)-3-[2-[(cyclohexylamino)(oxo)acetyl]hydrazinylidene]-N-[(4-methoxyphenyl)methyl]butanamide
Mycobacterium tuberculosis
pH 7.8, 37°C
0.00597
(3Z)-3-[2-[3-([(E)-[(4-methoxyphenyl)methylidene]amino]oxy)prop-1-en-2-yl]hydrazinylidene]-1,3-dihydro-2H-indol-2-one
Mycobacterium tuberculosis
pH 7.8, 37°C
0.0386
(5-(4-fluorophenylsulfonyl)-3-phenyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridin-1-yl)(phenyl)methanone
Mycobacterium tuberculosis
pH and temperature not specified in the publication
0.0012
(Z)-N'-(3-(5-(benzo[d][1,3]dioxol-5-ylmethylene)-4-oxo-2-thioxothiazolidin-3-yl)propanoyl)nicotinohydrazide
Mycobacterium tuberculosis
pH 7.8, 37°C
0.0391
1-(4-(1-benzoyl-3-phenyl-6,7-dihydro-1H-pyrazolo[4,3-c]pyridin-5(4H)-ylsulfonyl)phenyl)ethanone
Mycobacterium tuberculosis
pH and temperature not specified in the publication
0.0821
1-benzoyl-N-(4-bromophenyl)-3-phenyl-6,7-dihydro-1Hpyrazolo[4,3-c]pyridine-5(4H)-carboxamide
Mycobacterium tuberculosis
pH and temperature not specified in the publication
0.0218
1-benzoyl-N-(4-nitrophenyl)-3-phenyl-6,7-dihydro-1Hpyrazolo[4,3-c]pyridine-5(4H)-carboxamide
Mycobacterium tuberculosis
pH and temperature not specified in the publication
0.0382
1-benzoyl-N-(naphthalen-1-yl)-3-phenyl-6,7-dihydro-1Hpyrazolo[4,3-c]pyridine-5(4H)-carboxamide
Mycobacterium tuberculosis
pH and temperature not specified in the publication
0.01872
2-(5-nitrofuran-2-carboxamido)-6-(4-nitrophenylcarbamothioyl)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
Mycobacterium tuberculosis
pH and temperature not specified in the publication
0.025
2-(5-nitrofuran-2-carboxamido)-6-(4-nitrophenylsulfonyl)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
Mycobacterium tuberculosis
above, pH and temperature not specified in the publication
0.00207
2-methyl-N'-(3,4,5-trimethoxybenzylidene)benzo[d]imidazo[2,1-b]thiazole-3-carbohydrazide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00705
2-methyl-N'-(3,4,5-trimethoxybenzylidene)imidazo[1,2-a]pyridine-3-carbohydrazide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.0092
2-methyl-N'-(3-nitrobenzoyl)imidazo[1,2-a]pyridine-3-carbohydrazide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00531
2-methyl-N'-(4-(trifluoromethyl)benzylidene)benzo[d]imidazo[2,1-b]thiazole-3-carbohydrazide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00818
2-methyl-N'-(4-(trifluoromethyl)benzylidene)imidazo[1,2-a]pyridine-3-carbohydrazide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00583
2-methyl-N'-(4-methylbenzoyl)benzo[d]imidazo[2,1-b]thiazole-3-carbohydrazide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00335
2-methyl-N'-(4-methylbenzoyl)imidazo[1,2-a]pyridine-3-carbohydrazide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00746
2-methyl-N'-(4-methylbenzylidene)imidazo[1,2-a]pyridine-3-carbohydrazide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.025
2-methyl-N'-(4-nitrobenzylidene)imidazo[1,2-a]pyridine-3-carbohydrazide
Mycobacterium tuberculosis
above, pH 7.8, 37°C, recombinant enzyme
0.00053
2-methyl-N'-(4-phenoxybenzoyl)benzo[d]imidazo[2,1-b]thiazole-3-carbohydrazide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00722
2-methyl-N'-(4-phenoxybenzoyl)imidazo[1,2-a]pyridine-3-carbohydrazide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00701
2-methyl-N-(3-(trifluoromethyl)phenyl)imidazo[1,2-a]pyridine-3-carboxamide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.025
2-methyl-N-(pyridin-2-yl)imidazo[1,2-a]pyridine-3-carboxamide
Mycobacterium tuberculosis
above, pH 7.8, 37°C, recombinant enzyme
0.00577
2-methyl-N-phenethylimidazo[1,2-a]pyridine-3-carboxamide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00103
2-methyl-N-phenylbenzo[d]imidazo[2,1-b]thiazole-3-carboxamide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.01283
2-methyl-N-phenylimidazo[1,2-a]pyridine-3-carboxamide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
460
4-[(4-[[(5-tert-butyl-4,5,6,7-tetrahydro-1,2-benzisoxazol-3-yl)carbonyl]amino]-1H-pyrazol-1-yl)methyl]benzoic acid
Mycobacterium tuberculosis
-
140
5-tert-butyl-N-(1-[4-[(2-phenylethyl)carbamoyl]benzyl]-1H-pyrazol-4-yl)-4,5,6,7-tetrahydro-1,2-benzisoxazole-3-carboxamide
Mycobacterium tuberculosis
-
61000
5-tert-butyl-N-1H-pyrazol-4-yl-4,5,6,7-tetrahydro-1,2-benzisoxazole-3-carboxamide
Mycobacterium tuberculosis
-
130
5-tert-butyl-N-[1-(2,4-difluorobenzyl)-1H-pyrazol-4-yl]-4,5,6,7-tetrahydro-1,2-benzisoxazole-3-carboxamide
Mycobacterium tuberculosis
-
160
5-tert-butyl-N-[1-(2-iodobenzyl)-1H-pyrazol-4-yl]-4,5,6,7-tetrahydro-1,2-benzisoxazole-3-carboxamide
Mycobacterium tuberculosis
-
120
5-tert-butyl-N-[1-(2-methylbenzyl)-1H-pyrazol-4-yl]-4,5,6,7-tetrahydro-1,2-benzisoxazole-3-carboxamide
Mycobacterium tuberculosis
-
140
5-tert-butyl-N-[1-(4-chlorobenzyl)-1H-pyrazol-4-yl]-4,5,6,7-tetrahydro-1,2-benzisoxazole-3-carboxamide
Mycobacterium tuberculosis
-
150
5-tert-butyl-N-[1-(4-fluorobenzyl)-1H-pyrazol-4-yl]-4,5,6,7-tetrahydro-1,2-benzisoxazole-3-carboxamide
Mycobacterium tuberculosis
-
90
5-tert-butyl-N-[1-(naphthalen-2-ylmethyl)-1H-pyrazol-4-yl]-4,5,6,7-tetrahydro-1,2-benzisoxazole-3-carboxamide
Mycobacterium tuberculosis
-
7130
5-tert-butyl-N-[4-carbamoyl-3-(4-methoxybenzyl)isoxazol-5-yl]-4,5,6,7-tetrahydro-1,2-benzisoxazole-3-carboxamide
Mycobacterium tuberculosis
-
0.025
6-(4-acetylphenylsulfonyl)-2-(5-nitrofuran-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
Mycobacterium tuberculosis
above, pH and temperature not specified in the publication
0.025
6-(4-acetylphenylsulfonyl)-2-(5-nitrothiophene-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
Mycobacterium tuberculosis
above, pH and temperature not specified in the publication
0.025
6-(4-bromophenylsulfonyl)-2-(5-nitrofuran-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
Mycobacterium tuberculosis
above, pH and temperature not specified in the publication
0.01422
6-(4-bromophenylsulfonyl)-2-(5-nitrothiophene-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
Mycobacterium tuberculosis
pH and temperature not specified in the publication
0.01916
6-(4-chlorophenylcarbamothioyl)-2-(5-nitrofuran-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
Mycobacterium tuberculosis
pH and temperature not specified in the publication
0.00628
6-(4-chlorophenylcarbamothioyl)-2-(5-nitrothiophene-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
Mycobacterium tuberculosis
pH and temperature not specified in the publication
0.025
6-(4-chlorophenylcarbamoyl)-2-(5-nitrofuran-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
Mycobacterium tuberculosis
above, pH and temperature not specified in the publication
0.01022
6-(4-chlorophenylcarbamoyl)-2-(5-nitrothiophene-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
Mycobacterium tuberculosis
pH and temperature not specified in the publication
0.02086
6-(4-fluorophenylcarbamothioyl)-2-(5-nitrofuran-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
Mycobacterium tuberculosis
pH and temperature not specified in the publication
0.01016
6-(4-fluorophenylcarbamothioyl)-2-(5-nitrothiophene-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
Mycobacterium tuberculosis
pH and temperature not specified in the publication
0.01756
6-(4-fluorophenylsulfonyl)-2-(5-nitrofuran-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
Mycobacterium tuberculosis
pH and temperature not specified in the publication
0.01172
6-(4-fluorophenylsulfonyl)-2-(5-nitrothiophene-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
Mycobacterium tuberculosis
pH and temperature not specified in the publication
0.01506
6-(4-methoxyphenylcarbamoyl)-2-(5-nitrofuran-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
Mycobacterium tuberculosis
pH and temperature not specified in the publication
0.0145
6-(4-methoxyphenylcarbamoyl)-2-(5-nitrothiophene-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
Mycobacterium tuberculosis
pH and temperature not specified in the publication
0.02033
6-(4-methoxyphenylsulfonyl)-2-(5-nitrofuran-2-arboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
Mycobacterium tuberculosis
pH and temperature not specified in the publication
0.01905
6-(4-methoxyphenylsulfonyl)-2-(5-nitrothiophene-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
Mycobacterium tuberculosis
pH and temperature not specified in the publication
0.00911
6-(4-nitrophenylcarbamothioyl)-2-(5-nitrothiophene-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
Mycobacterium tuberculosis
pH and temperature not specified in the publication
0.01979
6-(4-nitrophenylcarbamoyl)-2-(5-nitrofuran-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
Mycobacterium tuberculosis
pH and temperature not specified in the publication
0.00968
6-(4-nitrophenylcarbamoyl)-2-(5-nitrothiophene-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
Mycobacterium tuberculosis
pH and temperature not specified in the publication
0.00587
6-(4-nitrophenylsulfonyl)-2-(5-nitrothiophene-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
Mycobacterium tuberculosis
pH and temperature not specified in the publication
0.01702
6-(benzylcarbamothioyl)-2-(5-nitrofuran-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
Mycobacterium tuberculosis
pH and temperature not specified in the publication
0.01324
6-(benzylcarbamothioyl)-2-(5-nitrothiophene-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
Mycobacterium tuberculosis
pH and temperature not specified in the publication
0.01408
6-(benzylcarbamoyl)-2-(5-nitrofuran-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
Mycobacterium tuberculosis
pH and temperature not specified in the publication
0.01816
6-(benzylcarbamoyl)-2-(5-nitrothiophene-2-carboxamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
Mycobacterium tuberculosis
pH and temperature not specified in the publication
0.00561
6-methyl-N'-(3,4,5-trimethoxybenzylidene)imidazo[2,1-b]thiazole-5-carbohydrazide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00067
6-methyl-N'-(4-(trifluoromethyl)benzylidene)imidazo[2,1-b]thiazole-5-carbohydrazide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00499
6-methyl-N'-(4-methylbenzoyl)imidazo[2,1-b]thiazole-5-carbohydrazide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00123
6-methyl-N'-(4-phenoxybenzoyl)imidazo[2,1-b]thiazole-5-carbohydrazide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00074
6-methyl-N-phenylimidazo[2,1-b]thiazole-5-carboxamide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00767
ethyl 2-[[(2,4,6-trioxotetrahydropyrimidin-5(2H)-ylidene)methyl]amino]-1,3-benzothiazole-6-carboxylate
Mycobacterium tuberculosis
pH 7.8, 37°C
160
methyl 4-[(4-[[(5-tert-butyl-4,5,6,7-tetrahydro-1,2-benzisoxazol-3-yl)carbonyl]amino]-1H-pyrazol-1-yl)methyl]benzoate
Mycobacterium tuberculosis
-
0.02244
methyl 6-amino-4-(benzyloxy)-1H-indole-2-carboxylate
Mycobacterium tuberculosis
-
pH and temperature not specified in the publication
0.00139
N'-(1-naphthoyl)-2-methylbenzo[d]imidazo[2,1-b]thiazole-3-carbohydrazide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.0019
N'-(1-naphthoyl)-2-methylimidazo[1,2-a]pyridine-3-carbohydrazide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00064
N'-(1-naphthoyl)-6-methylimidazo[2,1-b]thiazole-5-carbohydrazide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00513
N'-(2,4-dichlorobenzoyl)-2-methylimidazo[1,2-a]pyridine-3-carbohydrazide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00821
N'-(2-methoxybenzoyl)-2-methylimidazo[1,2-a]pyridine-3-carbohydrazide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00648
N'-(3,5-dinitrobenzoyl)-2-methylimidazo[1,2-a]pyridine-3-carbohydrazide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00537
N'-(4-(benzyloxy)benzylidene)-2-methylimidazo[1,2-a]pyridine-3-carbohydrazide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00146
N'-(4-(dimethylamino)benzylidene)-2-methylbenzo[d]imidazo[2,1-b]thiazole-3-carbohydrazide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.0025
N'-(4-(dimethylamino)benzylidene)-6-methylimidazo[2,1-b]thiazole-5-carbohydrazide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00102
N'-(4-bromobenzylidene)-2-methylbenzo[d]imidazo[2,1-b]thiazole-3-carbohydrazide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00443
N'-(4-bromobenzylidene)-2-methylimidazo[1,2-a]pyridine-3-carbohydrazide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.0012
N'-(4-bromobenzylidene)-6-methylimidazo[2,1-b]thiazole-5-carbohydrazide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00377
N'-(4-fluorobenzylidene)-2-methylimidazo[1,2-a]pyridine-3-carbohydrazide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00749
N'-(4-hydroxybenzylidene)-2-methylimidazo[1,2-a]pyridine-3-carbohydrazide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00637
N'-(4-methoxybenzylidene)-2-methylimidazo[1,2-a]pyridine-3-carbohydrazide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00291
N'-(cyclohexanecarbonyl)-2-methylbenzo[d]imidazo[2,1-b]thiazole-3-carbohydrazide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.0077
N'-(cyclohexanecarbonyl)-2-methylimidazo[1,2-a]pyridine-3-carbohydrazide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00538
N'-(cyclohexanecarbonyl)-6-methylimidazo[2,1-b]thiazole-5-carbohydrazide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00893
N'-(furan-2-carbonyl)-2-methylimidazo[1,2-a]pyridine-3-carbohydrazide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.02633
N'-([[5-(4-hydroxyphenyl)-4-methyl-4H-1,2,4-triazol-3-yl]sulfanyl]acetyl)pyridine-4-carbohydrazide
Mycobacterium tuberculosis
pH 7.8, 37°C
0.0011
N'-benzoyl-2-methylbenzo[d]imidazo[2,1-b]thiazole-3-carbohydrazide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00354
N'-benzoyl-2-methylimidazo[1,2-a]pyridine-3-carbohydrazide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00531
N'-benzoyl-6-methylimidazo[2,1-b]thiazole-5-carbohydrazide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00215
N'-benzylidene-2-methylbenzo[d]imidazo[2,1-b]thiazole-3-carbohydrazide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00486
N'-benzylidene-2-methylimidazo[1,2-a]pyridine-3-carbohydrazide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00058
N'-benzylidene-6-methylimidazo[2,1-b]thiazole-5-carbohydrazide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
97
N-(1-benzyl-1H-pyrazol-4-yl)-5-tert-butyl-4,5,6,7-tetrahydro-1,2-benzisoxazole-3-carboxamide
Mycobacterium tuberculosis
-
0.00359
N-(3-benzamidobenzoyl)tryptophan
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00052
N-(4-bromophenyl)-2-methylbenzo[d]imidazo[2,1-b]thiazole-3-carboxamide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00695
N-(4-bromophenyl)-2-methylimidazo[1,2-a]pyridine-3-carboxamide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00069
N-(4-bromophenyl)-6-methylimidazo[2,1-b]thiazole-5-carboxamide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.0026
N-(4-chlorophenyl)-2-methylimidazo[1,2-a]pyridine-3-carboxamide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.0021
N-(4-ethoxyphenyl)-2-methylbenzo[d]imidazo[2,1-b]thiazole-3-carboxamide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.025
N-(4-ethoxyphenyl)-2-methylimidazo[1,2-a]pyridine-3-carboxamide
Mycobacterium tuberculosis
above, pH 7.8, 37°C, recombinant enzyme
0.00583
N-(4-methoxyphenyl)-6-methylimidazo[2,1-b]thiazole-5-carboxamide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00281
N-(furan-2-ylmethyl)-2-methylimidazo[1,2-a]pyridine-3-carboxamide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00084
N-benzyl-2-methylbenzo[d]imidazo[2,1-b]thiazole-3-carboxamide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00274
N-benzyl-2-methylimidazo[1,2-a]pyridine-3-carboxamide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00106
N-benzyl-6-methylimidazo[2,1-b]thiazole-5-carboxamide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00102
N-cyclohexyl-2-methylbenzo[d]imidazo[2,1-b]thiazole-3-carboxamide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00199
N-cyclohexyl-2-methylimidazo[1,2-a]pyridine-3-carboxamide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.002
N-cyclohexyl-6-methylimidazo[2,1-b]thiazole-5-carboxamide
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
140
N-[1-(2-bromobenzyl)-1H-pyrazol-4-yl]-5-tert-butyl-4,5,6,7-tetrahydro-1,2-benzisoxazole-3-carboxamide
Mycobacterium tuberculosis
-
210
N-[1-[4-(benzylcarbamoyl)benzyl]-1H-pyrazol-4-yl]-5-tert-butyl-4,5,6,7-tetrahydro-1,2-benzisoxazole-3-carboxamide
Mycobacterium tuberculosis
-
0.03878
N-[2-(cyclohexylamino)-1-(3,4-dihydroxyphenyl)-2-oxoethyl]-2-([2-[(5-methyl-1,2-oxazol-3-yl)amino]-2-oxoethyl]sulfanyl)-N-phenylacetamide
Mycobacterium tuberculosis
pH 7.8, 37°C
0.01006
N-[3-(2-chlorobenzamido)benzoyl]tryptophan
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00562
N-[3-(2-fluorobenzamido)benzoyl]tryptophan
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.01087
N-[3-(3-chlorobenzamido)benzoyl]tryptophan
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00288
N-[3-(3-nitrobenzamido)benzoyl]tryptophan
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00521
N-[3-(4-chlorobenzamido)benzoyl]tryptophan
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00228
N-[3-(4-fluorobenzamido)benzoyl]tryptophan
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00954
N-[3-(4-nitrobenzamido)benzoyl]tryptophan
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00445
N-[3-(4-tert-butylbenzamido)benzoyl]tryptophan
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00682
N-[3-([[(furan-2-yl)oxy]carbonyl]amino)benzoyl]tryptophan
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00774
N-[3-[(cyclohexanecarbonyl)amino]benzoyl]tryptophan
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00714
N-[3-[(cyclopentanecarbonyl)amino]benzoyl]tryptophan
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.01068
N-[3-[(pyrazine-2-carbonyl)amino]benzoyl]tryptophan
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.0093
N-[3-[(thiophene-2-carbonyl)amino]benzoyl]tryptophan
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.01563
N-[3-[2-(4-methoxyphenyl)acetamido]benzoyl]tryptophan
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.00852
N-[3-[2-(trifluoromethyl)benzamido]benzoyl]tryptophan
Mycobacterium tuberculosis
pH 7.8, 37°C, recombinant enzyme
0.3984
nafronyl oxalate
Mycobacterium tuberculosis
-
pH and temperature not specified in the publication
250
tert-butyl 4-[(4-[[(5-tert-butyl-4,5,6,7-tetrahydro-1,2-benzisoxazol-3-yl)carbonyl]amino]-1H-pyrazol-1-yl)methyl]benzoate
Mycobacterium tuberculosis
-
0.02472
[4-[2-(3,4-dihydroxyphenyl)-4-phenyl-1H-imidazol-5-yl]phenyl](phenyl)methanone
Mycobacterium tuberculosis
pH 7.8, 37°C
0.2507
actinomycin D
Mycobacterium tuberculosis
-
pH and temperature not specified in the publication
0.2507
actinomycin D
Mycobacterium tuberculosis
pH and temperature not specified in the publication
0.025
ethambutol
Mycobacterium tuberculosis
above, pH 7.8, 37°C, recombinant enzyme
0.025
ethambutol
Mycobacterium tuberculosis
-
above, pH 7.8, 37°C, recombinant enzyme
0.025
isoniazid
Mycobacterium tuberculosis
above, pH 7.8, 37°C, recombinant enzyme
0.025
isoniazid
Mycobacterium tuberculosis
-
above, pH 7.8, 37°C, recombinant enzyme
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Cronan, J.E.; Littel, K.J.; Jackowski, S.
Genetic and biochemical analyses of pantothenate biosynthesis in Escherichia coli and Salmonella typhimurium
J. Bacteriol.
149
916-922
1982
Escherichia coli, Salmonella enterica subsp. enterica serovar Typhimurium
brenda
Cronan, J.E.
Enzymatic synthesis of beta-[U-14C]alanine and D-[1,2,3-14C]pantothenate of high specific radioactivity
Anal. Biochem.
103
377-380
1980
Escherichia coli
brenda
Miyatake, K.; Nakano, Y.; Kitaoka, S.
Pantothenate synthetase from Escherichia coli [D-pantoate:beta-alanine ligase (AMP-forming), EC 6.3.2.1]
Methods Enzymol.
62
215-219
1979
Escherichia coli
brenda
Miyatake, K.; Nakano, Y.; Kitaoka, S.
Enzymological properties of pantothenate synthetase from Escherichia coli B
J. Nutr. Sci. Vitaminol.
24
243-253
1978
Escherichia coli
brenda
Miyatake, K.; Nakano, Y.; Kitaoka, S.
Some properties of pantothenate synthetase partially purified from Escherichia coli B
Bull. Univ. Osaka Prefect
27
57-67
1975
Escherichia coli
-
brenda
Miyatake, K.; Nakano, Y.; Kitaoka, S.
Pantothenate synthetase of Escherichia coli B. I. Physicochemical properties
J. Biochem.
79
673-678
1976
Escherichia coli, Escherichia coli B / ATCC 11303
brenda
Miyatake, K.; Nakano, Y.; Kitaoka, S.
Isotopic determination and optimum reaction conditions of pantothenic acid synthetase
Agric. Biol. Chem.
37
1205-1207
1973
Escherichia coli
-
brenda
Ginoza, H.S.; Altenbern, R.A.
The pantothenate-synthesizing enzyme in cell-free extracts of Brucella abortus, strain 19
Arch. Biochem. Biophys.
56
537-541
1955
Brucella abortus, Brucella abortus 19
brenda
Baillie, A.C.; Cornell, C.L.; Wright, B.J.; Wright, K.
Synthesis of potential inhibitors of the enzyme pantothenate synthetase
Tetrahedron Lett.
33
5133-5136
1992
Escherichia coli
-
brenda
Genschel, U.; Powell, C.A.; Abell, C.; Smith, A.G.
The final step of pantothenate biosynthesis in higher plants: cloning and characterization of pantothenate synthetase from Lotus japonicus and Oryza sativum (rice)
Biochem. J.
341
669-678
1999
Lotus japonicus (O24035), Oryza sativa (O24210)
-
brenda
Zheng, R.; Blanchard, J.S.
Steady-state and pre-steady-state kinetic analysis of Mycobacterium tuberculosis pantothenate synthetase
Biochemistry
40
12904-12912
2001
Mycobacterium tuberculosis
brenda
Williams, L.; Zheng, R.; Blanchard, J.S.; Raushel, F.M.
Positionoal isotope exchange analysis of the pantothenate synthetase reaction
Biochemistry
42
5108-5113
2003
Mycobacterium tuberculosis
brenda
Perez-Espinosa, A.; Roldan-Arjona, T.; Ruiz-Rubio, M.
Pantothenate synthetase from Fusarium oxysporum f. sp. lycopersici is induced by alpha-tomatine
Mol. Genet. Genomics
265
922-929
2001
Fusarium oxysporum (Q96VJ9), Fusarium oxysporum
brenda
Wang, S.; Eisenberg, D.
Crystal structures of a pantothenate synthetase from M. tuberculosis and its complexes with substrates and a reaction intermediate
Protein Sci.
12
1097-1108
2003
Mycobacterium tuberculosis
brenda
von Delft, F.; Lewendon, A.; Dhanaraj, V.; Blundell, T.L.; Abell, C.; Smith, A.G.
The crystal structure of E. coli pantothenate synthetase confirms it as a member of the cytidylyltransferase superfamily
Structure
9
439-450
2001
Escherichia coli
brenda
Zheng, R.; Dam, T.K.; Brewer, C.F.; Blanchard, J.S.
Active site residues in Mycobacterium tuberculosis pantothenate synthetase required in the formation and stabilization of the adenylate intermediate
Biochemistry
43
7171-7178
2004
Mycobacterium tuberculosis
brenda
Ottenhof, H.H.; Ashurst, J.L.; Whitney, H.M.; Saldanha, S.A.; Schmitzberger, F.; Gweon, H.S.; Blundell, T.L.; Abell, C.; Smith, A.G.
Organisation of the pantothenate (vitamin B5) biosynthesis pathway in higher plants
Plant J.
37
61-72
2004
Arabidopsis thaliana
brenda
Mitra, A.; Chakrabarti, K.S.; Hameed, M.S.S.; Srinivas, K.V.; Kumar, G.S.; Sarma, S.P.
High level expression of peptides and proteins using cytochrome b5 as a fusion host
Protein Expr. Purif.
41
84-97
2005
Escherichia coli
brenda
Wang, S.; Eisenberg, D.
Crystal structure of the pantothenate synthetase from Mycobacterium tuberculosis, snapshots of the enzyme in action
Biochemistry
45
1554-1561
2006
Mycobacterium tuberculosis (P9WIL5), Mycobacterium tuberculosis, Mycobacterium tuberculosis H37Rv (P9WIL5)
brenda
Jonczyk, R.; Genschel, U.
Molecular adaptation and allostery in plant pantothenate synthetases
J. Biol. Chem.
281
37435-37446
2006
Arabidopsis thaliana, Escherichia coli
brenda
White, E.L.; Southworth, K.; Ross, L.; Cooley, S.; Gill, R.B.; Sosa, M.I.; Manouvakhova, A.; Rasmussen, L.; Goulding, C.; Eisenberg, D.; Fletcher, T.M.
A novel inhibitor of Mycobacterium tuberculosis pantothenate synthetase
J. Biomol. Screen.
12
100-105
2007
Mycobacterium tuberculosis
brenda
Tuck, K.L.; Saldanha, S.A.; Birch, L.M.; Smith, A.G.; Abell, C.
The design and synthesis of inhibitors of pantothenate synthetase
Org. Biomol. Chem.
4
3598-3610
2006
Escherichia coli (P31663)
brenda
Velaparthi, S.; Brunsteiner, M.; Uddin, R.; Wan, B.; Franzblau, S.G.; Petukhov, P.A.
5-tert-butyl-N-pyrazol-4-yl-4,5,6,7-tetrahydrobenzo[d]isoxazole-3-carboxamide derivatives as novel potent inhibitors of Mycobacterium tuberculosis pantothenate synthetase: initiating a quest for new antitubercular drugs
J. Med. Chem.
51
1999-2002
2008
Mycobacterium tuberculosis (P9WIL5), Mycobacterium tuberculosis, Mycobacterium tuberculosis H37Rv (P9WIL5)
brenda
Jonczyk, R.; Ronconi, S.; Rychlik, M.; Genschel, U.
Pantothenate synthetase is essential but not limiting for pantothenate biosynthesis in Arabidopsis
Plant Mol. Biol.
66
1-14
2008
Escherichia coli, Arabidopsis thaliana (Q9FKB3), Arabidopsis thaliana
brenda
Chakrabarti, K.S.; Thakur, K.G.; Gopal, B.; Sarma, S.P.
X-ray crystallographic and NMR studies of pantothenate synthetase provide insights into the mechanism of homotropic inhibition by pantoate
FEBS J.
277
697-712
2010
Escherichia coli (P31663), Escherichia coli
brenda
Sledz, P.; Silvestre, H.L.; Hung, A.W.; Ciulli, A.; Blundell, T.L.; Abell, C.
Optimization of the interligand overhauser effect for fragment linking: application to inhibitor discovery against Mycobacterium tuberculosis pantothenate synthetase
J. Am. Chem. Soc.
132
4544-4545
2010
Mycobacterium tuberculosis (P9WIL5), Mycobacterium tuberculosis, Mycobacterium tuberculosis H37Rv (P9WIL5)
brenda
Satoh, A.; Konishi, S.; Tamura, H.; Stickland, H.G.; Whitney, H.M.; Smith, A.G.; Matsumura, H.; Inoue, T.
Substrate-induced closing of the active site revealed by the crystal structure of pantothenate synthetase from Staphylococcus aureus
Biochemistry
49
6400-6410
2010
Staphylococcus aureus (Q2FV22), Staphylococcus aureus
brenda
Yang, Y.; Gao, P.; Liu, Y.; Ji, X.; Gan, M.; Guan, Y.; Hao, X.; Li, Z.; Xiao, C.
A discovery of novel Mycobacterium tuberculosis pantothenate synthetase inhibitors based on the molecular mechanism of actinomycin D inhibition
Bioorg. Med. Chem. Lett.
21
3943-3946
2011
Mycobacterium tuberculosis
brenda
Tan, Y.S.; Fuentes, G.; Verma, C.
A comparison of the dynamics of pantothenate synthetase from M. tuberculosis and E. coli: computational studies
Proteins
79
1715-1727
2011
Escherichia coli, Mycobacterium tuberculosis
brenda
Samala, G.; Devi, P.; Nallangi, R.; Sridevi, J.; Saxena, S.; Yogeeswari, P.; Sriram, D.
Development of novel tetrahydrothieno[2,3-c]pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: molecular hybridization from known antimycobacterial leads
Bioorg. Med. Chem.
22
1938-1947
2014
Mycobacterium tuberculosis (P9WIL5), Mycobacterium tuberculosis, Mycobacterium tuberculosis H37Rv (P9WIL5)
brenda
Samala, G.; Devi, P.B.; Nallangi, R.; Yogeeswari, P.; Sriram, D.
Development of 3-phenyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine derivatives as novel Mycobacterium tuberculosis pantothenate synthetase inhibitors
Eur. J. Med. Chem.
69
356-364
2013
Mycobacterium tuberculosis (P9WIL5), Mycobacterium tuberculosis, Mycobacterium tuberculosis H37Rv (P9WIL5)
brenda
Kumar, A.; Casey, A.; Odingo, J.; Kesicki, E.A.; Abrahams, G.; Vieth, M.; Masquelin, T.; Mizrahi, V.; Hipskind, P.A.; Sherman, D.R.; Parish, T.
A high-throughput screen against pantothenate synthetase (PanC) identifies 3-biphenyl-4-cyanopyrrole-2-carboxylic acids as a new class of inhibitor with activity against Mycobacterium tuberculosis
PLoS ONE
8
e72786
2013
Mycobacterium tuberculosis (P9WIL5), Mycobacterium tuberculosis, Mycobacterium tuberculosis H37Rv (P9WIL5)
brenda
Samala, G.; Nallangi, R.; Devi, P.B.; Saxena, S.; Yadav, R.; Sridevi, J.P.; Yogeeswari, P.; Sriram, D.
Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors
Bioorg. Med. Chem.
22
4223-4232
2014
Mycobacterium tuberculosis (P9WIL5), Mycobacterium tuberculosis, Mycobacterium tuberculosis ATCC 27294 / ATCC 25618 / H37Rv (P9WIL5)
brenda
Samala, G.; Devi, P.B.; Saxena, S.; Meda, N.; Yogeeswari, P.; Sriram, D.
Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors
Bioorg. Med. Chem.
24
1298-1307
2016
Mycobacterium tuberculosis (P9WIL5), Mycobacterium tuberculosis, Mycobacterium tuberculosis ATCC 27294 / ATCC 25618 / H37Rv (P9WIL5)
brenda
Hung, A.W.; Silvestre, H.L.; Wen, S.; George, G.P.; Boland, J.; Blundell, T.L.; Ciulli, A.; Abell, C.
Optimization of inhibitors of Mycobacterium tuberculosis pantothenate synthetase based on group efficiency analysis
ChemMedChem
11
38-42
2016
Mycobacterium tuberculosis (P9WIL5), Mycobacterium tuberculosis, Mycobacterium tuberculosis ATCC 25618 / H37Rv (P9WIL5)
brenda
Devi, P.B.; Samala, G.; Sridevi, J.P.; Saxena, S.; Alvala, M.; Salina, E.G.; Sriram, D.; Yogeeswari, P.
Structure-guided design of thiazolidine derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors
ChemMedChem
9
2538-2547
2014
Mycobacterium tuberculosis (P9WIL5), Mycobacterium tuberculosis, Mycobacterium tuberculosis ATCC 27294 / ATCC 25618 / H37Rv (P9WIL5)
brenda
Ntie-Kang, F.; Kannan, S.; Wichapong, K.; Owono Owono, L.; Sippl, W.; Megnassan, E.
Binding of pyrazole-based inhibitors to Mycobacterium tuberculosis pantothenate synthetase docking and MM-GB(PB)SA analysis
Mol. Biosyst.
10
223-239
2014
Mycobacterium tuberculosis (P9WIL5), Mycobacterium tuberculosis, Mycobacterium tuberculosis ATCC 25618 / H37Rv (P9WIL5)
brenda
Devi, P.B.; Jogula, S.; Reddy, A.P.; Saxena, S.; Sridevi, J.P.; Sriram, D.; Yogeeswari, P.
Design of novel Mycobacterium tuberculosis pantothenate synthetase inhibitors virtual screening, synthesis and in vitro biological activities
Mol. Inform.
34
147-159
2015
Mycobacterium tuberculosis (P9WIL5), Mycobacterium tuberculosis, Mycobacterium tuberculosis ATCC 25618 / H37Rv (P9WIL5)
brenda
Pandey, B.; Grover, S.; Goyal, S.; Kumari, A.; Singh, A.; Jamal, S.; Kaur, J.; Grover, A.
Alanine mutation of the catalytic sites of pantothenate synthetase causes distinct conformational changes in the ATP binding region
Sci. Rep.
8
903
2018
Mycobacterium tuberculosis (P9WIL5), Mycobacterium tuberculosis, Mycobacterium tuberculosis ATCC 25618 / H37Rv (P9WIL5)
brenda